News from all angles
(MedPage Today) -- For de novo coronary lesions, drug-coated balloons (DCBs) were just as effective as standard drug-eluting stents, the TRANSFORM II trial showed. Among patients with native coronary…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network